Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysis

被引:17
|
作者
Liu, Yan Ping [3 ]
Hao, Pan Pan [1 ,2 ]
Zhang, Ming Xiang [1 ,2 ]
Zhang, Cheng [1 ,2 ]
Gao, Fei [1 ,2 ]
Zhang, Yun [1 ,2 ]
Chen, Yu Guo [1 ,2 ]
机构
[1] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China
[2] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250012, Peoples R China
[3] Shandong Univ, Sch Med, Inst Expt Nucl Med, Jinan 250012, Peoples R China
关键词
PERCUTANEOUS CORONARY INTERVENTION; OF-FUNCTION POLYMORPHISM; STENT THROMBOSIS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; TREATED PATIENTS; RISK; GENOTYPE; CYP2C19-ASTERISK-2; ACTIVATION;
D O I
10.1016/j.thromres.2011.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:593 / 594
页数:2
相关论文
共 50 条
  • [21] Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
    Li, Changqing
    Jia, Weihua
    Li, Jian
    Li, Fangfei
    Ma, Jing
    Zhou, Lichun
    BMC NEUROLOGY, 2021, 21 (01)
  • [22] RISK OF CARDIOVASCULAR EVENTS IN CORONARY ARTERY DISEASE PATIENTS ON CLOPIDOGREL WITH AND WITHOUT CYP2C19*2 POLYMORPHISM: AN UPDATED COMPREHENSIVE META-ANALYSIS
    Singh, Mukesh
    Shah, Tejaskumar
    Adigopula, Sasikanth
    Jawad, Evyan
    Khosla, Sandeep
    Arora, Rohit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E2043 - E2043
  • [23] Effect of PON1 and CYP2C19 genetic variants on the pharmacokinetics and pharmacodynamics of clopidogrel
    Hulot, J-S.
    Collet, J-P.
    Cayla, G.
    Sylvain, J.
    Finzi, J.
    Allanic, F.
    Bellemain-Appaix, A.
    Anzaha, G.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2011, 32 : 341 - 342
  • [24] CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment
    Hou, Xumin
    Han, Wenzheng
    Gan, Qian
    Liu, Yuan
    Fang, Weiyi
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (05)
  • [25] Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients With Coronary Artery Disease Treated With Clopidogrel: A Meta-Analysis
    Clifford, Cole
    Knoll, William
    Boudreau, Rene
    Barry, Quinton
    Visintini, Sarah
    Alhassani, Saad
    Laverdure, Morgane
    So, Derek
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B204 - B204
  • [26] CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel A Meta-Analysis
    Sorich, Michael J.
    Rowland, Andrew
    McKinnon, Ross A.
    Wiese, Michael D.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (06) : 895 - U387
  • [27] Association of CYP2C19*2 and*17 genetic variants with hypertension in Pakistani population
    Riaz, Sana
    Mansoor, Atika
    Siddiqi, Saima
    Tareen, Muhammad Usman
    Rubab, Sana
    Batool, Ayesha
    Anwarullah
    Sultan, Aneesa
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (04) : 851 - 855
  • [28] Association of CYP2C19*2 and *3 Genetic Variants with Essential Hypertension in Koreans
    Shin, Dong-Jik
    Kwon, Jisun
    Park, Ah-Ram
    Bae, Yousun
    Shin, Eun-Soon
    Park, Sungha
    Jang, Yangsoo
    YONSEI MEDICAL JOURNAL, 2012, 53 (06) : 1113 - 1119
  • [29] Meta-analysis of CYP2C19 association with efficacy and side effects of citalopram and escitalopram
    Fabbri, C.
    Tansey, K.
    Perlis, R.
    Hauser, J.
    Henigsberg, N.
    Maier, W.
    Mors, O.
    Placentino, A.
    Rietschel, M.
    Souery, D.
    Breen, G.
    Curtis, C.
    Sang-Hyuk, L.
    Newhouse, S.
    Patel, H.
    Guipponi, M.
    Perroud, N.
    Bondolfi, G.
    O'Donovan, M.
    Lewis, G.
    Biernacka, J.
    Weinshilboum, R.
    Farmer, A.
    Aitchison, K.
    Craig, I.
    McGuffin, P.
    Uher, R.
    Lewis, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S582 - S583
  • [30] Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: A meta-analysis based on 23,035 subjects
    Liu Mao
    Chen Jian
    Liu Changzhi
    Huang Dan
    Huang Suihua
    Tang Wenyi
    Wu Wei
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (10) : 517 - 527